Literature DB >> 8568244

Postnatal development of T cells in dogs with X-linked severe combined immunodeficiency.

R L Somberg1, A Tipold, B J Hartnett, P F Moore, P S Henthorn, P J Felsburg.   

Abstract

X-linked severe combined immunodeficiency disease (XSCID) in both humans and dogs results from mutations in the common gamma-chain, gamma c, which is a common component of the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15. Although human and canine XSCID share similar features, such as a failure to thrive, hypogammaglobulinemia, an absent T cell mitogenic response, and thymic dysplasia, near normal percentages of T cells are observed in some affected dogs, whereas XSCID boys have few, if any, circulating T cells. In this study, PBL were analyzed by flow cytometry beginning shortly after birth until 9 wk of age. XSCID dogs < 3 wk of age had an elevated number of B cells and were nearly devoid of T cells, phenotypically resembling most human XSCID patients. At 5 wk of age, however, T cells appeared in approximately one-half of the XSCID dogs, although the absolute number of T cells was one-third of normal in these dogs. While the percentage of CD45RA+ T cells in normal dogs gradually decreased with age from > 90% in neonates to < 40% by 3 to 5 yr of age, in XSCID dogs a rapid decline in the percentage of CD45RA+ T cells was observed, resulting in < 10% CD45RA+ T cells by 7 to 9 wk of age. Maternal engraftment was not detected in any of the XSCID dogs by using a sensitive PCR assay. The appearance of nonmaternally derived T cells in XSCID dogs that undergo a rapid switch from CD45RA+ to CD45RA- suggests that limited thymic emigration and peripheral expansion of T cells can occur in the absence of a functional gamma c.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568244

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

Review 2.  Canine X-linked severe combined immunodeficiency. A model for investigating the requirement for the common gamma chain (gamma c) in human lymphocyte development and function.

Authors:  P J Felsburg; R L Somberg; B J Hartnett; P S Henthorn; S R Carding
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

3.  Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.

Authors:  Suk See Ting-De Ravin; Douglas R Kennedy; Nora Naumann; Jeffrey S Kennedy; Uimook Choi; Brian J Hartnett; Gilda F Linton; Narda L Whiting-Theobald; Peter F Moore; William Vernau; Harry L Malech; Peter J Felsburg
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

Review 4.  Gene therapy studies in a canine model of X-linked severe combined immunodeficiency.

Authors:  Peter J Felsburg; Suk See De Ravin; Harry L Malech; Brian P Sorrentino; Christopher Burtner; Hans-Peter Kiem
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-24       Impact factor: 5.032

Review 5.  Thymopoiesis and T cell development in common gamma chain-deficient dogs.

Authors:  Peter J Felsburg; Brian J Hartnett; Terry A Gouthro; Paula S Henthorn
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.